5-Methoxytryptamine CAS 608-07-1

5-methoxytryptamine (5-MT) is a naturally occurring indoleamine compound with significant research value in the fields of neuroscience, pharmacology, and biochemistry. As a derivative of serotonin, 5-MT is widely distributed in nature and exists in various plants, animals, and even humans, playing multiple biological functions. Its discovery history is closely related to the overall study of serotonin compounds. Tryptamine, as a fundamental indoleamine structure, has been studied since the late 19th century. The confirmation of the core structure of serotonin is the basis for understanding 5-MT.

In 1907, British chemists George Barger and Henry Dale first isolated ergotamine from ergot fungus and described its chemical properties. This discovery laid the foundation for the subsequent research on various serotonin derivatives. In the early 20th century, scientists gradually recognized the universality of serotonin structures in bioactive substances, particularly in neurotransmitters and plant alkaloids.

In the 1930s and 1940s, with the advancement of analytical chemistry technology, especially the application of chromatographic separation technology and ultraviolet spectroscopy, scientists were able to separate and identify more serotonin derivatives from complex biological samples. During this period, researchers discovered various serotonin substances in animal brain tissues and various plants, creating conditions for the discovery of 5-methoxytryptamine. The exact discovery time of 5-methoxytryptamine can be traced back to the mid-1950s.

In 1955, American biochemist D.W. Woolley and a team of British chemists discovered this compound almost simultaneously in different biological samples. Woolley isolated a substance with strong biological activity while studying the skin secretions of toads, which was identified as 5-methoxytryptamine. Almost simultaneously, British researchers independently discovered this compound while studying pineal gland secretions. These findings mark the formal confirmation of 5-MT as an independent chemical entity. The early structural identification of 5-MT mainly relied on chemical degradation analysis, paper chromatography behavior, and UV absorption spectroscopy characteristics.

In 1957, Swiss chemist A Hofmann's team, known for their discovery of LSD, has completed the chemical total synthesis of 5-MT for the first time, providing a reliable reference standard for subsequent research. The establishment of synthetic routes has also enabled scientists to prepare isotope labeled 5-MT, greatly promoting its metabolic and pharmacological research. With the advancement of analytical techniques, researchers gradually revealed the widespread distribution of 5-MT in nature in the 1960s and 1970s

In 1962, plant chemists detected 5-MT in various leguminous plants (such as Acacia) and Asteraceae plants. It is particularly noteworthy that certain traditional medicinal plants such as Anadenanthera peregrina and psychedelic mushroom related plants contain high concentrations of 5-MT, which explains the psychoactive effects of these plants. The study of 5-MT in mammalian bodies is an important breakthrough.

In 1965, the research team of American scientist Julius Axelrod (later awarded the Nobel Prize for his research on catecholamines) discovered that the pineal gland was an important source of 5-MT. They demonstrated that 5-MT is a precursor substance for melatonin biosynthesis, which links 5-MT to circadian rhythm regulation. In the late 1970s, a Japanese research team also identified 5-MT in certain fungal and bacterial metabolites, expanding our understanding of its biological distribution.